Congress Trading They’re About to Pass — Legal but Debated
Lawmakers’ stock trades tied to bills they’re about to vote on have renewed debate over whether current rules protect...
Identify the Aristocrats ETF with the lowest fee and understand how that impacts long-term returns, including potential trade-offs.
20,652 articlesLawmakers’ stock trades tied to bills they’re about to vote on have renewed debate over whether current rules protect...
A high‑income ETF pays roughly 10% by writing options on Nasdaq-100 stocks, Nvidia among them. The strategy offers st...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...
June inflation cooled, sparking a rally in crypto markets. Ethereum led the way with a double‑digit gain, while Bitco...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...
Five cities are in a high-stakes chase to land a blockbuster deal tied to LeBron James, hoping for lasting local grow...
A yearly reshuffle of Medicare Part D pharmacy networks can swing out-of-pocket costs for maintenance meds. Investors...
As lawmakers race toward two July floor windows, the CLARITY Act stands as the key to how digital assets are classifi...
Palantir stock slipped from its peak, triggering questions about value, risk, and timing for late 2026. This guide br...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...